BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

465 related articles for article (PubMed ID: 34816283)

  • 1. Clinical Utility of F-18 Labeled Fibroblast Activation Protein Inhibitor (FAPI) for Primary Staging in Lung Adenocarcinoma: a Prospective Study.
    Li Y; Lin X; Li Y; Lv J; Hou P; Liu S; Chen P; Wang M; Zhou C; Wang X
    Mol Imaging Biol; 2022 Apr; 24(2):309-320. PubMed ID: 34816283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of
    Wang L; Tang G; Hu K; Liu X; Zhou W; Li H; Huang S; Han Y; Chen L; Zhong J; Wu H
    Radiology; 2022 Apr; 303(1):191-199. PubMed ID: 34981976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical utility of [
    Zhao L; Pang Y; Zheng H; Han C; Gu J; Sun L; Wu H; Wu S; Lin Q; Chen H
    Eur J Nucl Med Mol Imaging; 2021 Oct; 48(11):3606-3617. PubMed ID: 33792760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibroblast Activation Protein-Targeted PET/CT with
    Xu W; Cai J; Peng T; Meng T; Pang Y; Sun L; Wu H; Zhang J; Chen X; Chen H
    J Nucl Med; 2024 Jan; 65(1):40-51. PubMed ID: 37884330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Positron emission tomography and computed tomography with [
    Pang Y; Zhao L; Shang Q; Meng T; Zhao L; Feng L; Wang S; Guo P; Wu X; Lin Q; Wu H; Huang W; Sun L; Chen H
    Eur J Nucl Med Mol Imaging; 2022 Mar; 49(4):1322-1337. PubMed ID: 34651226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PET Imaging of Fibroblast Activation Protein in Various Types of Cancer Using
    Pang Y; Zhao L; Meng T; Xu W; Lin Q; Wu H; Zhang J; Chen X; Sun L; Chen H
    J Nucl Med; 2023 Mar; 64(3):386-394. PubMed ID: 36215571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of
    Pang Y; Zhao L; Luo Z; Hao B; Wu H; Lin Q; Sun L; Chen H
    Radiology; 2021 Feb; 298(2):393-402. PubMed ID: 33258746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FAPI Compared with FDG PET/CT for Diagnosis of Primary and Metastatic Lung Cancer.
    Wei Y; Ma L; Li P; Lu J; Ren J; Yan S; Wu H; Yuan S; Fu Z; Yu J
    Radiology; 2023 Aug; 308(2):e222785. PubMed ID: 37552075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PET/CT imaging fibroblast activation protein in initial colorectal cancer: compared to 18 F-FDG PET/CT.
    Dong Y; Sun P; Wu H; Zhong J; Cao M; Tang G; Zhou W
    Nucl Med Commun; 2023 Nov; 44(11):1011-1019. PubMed ID: 37661771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The potential utility of [
    Lan L; Liu H; Wang Y; Deng J; Peng D; Feng Y; Wang L; Chen Y; Qiu L
    Eur J Nucl Med Mol Imaging; 2022 Feb; 49(3):963-979. PubMed ID: 34410435
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Fu H; Wu J; Huang J; Sun L; Wu H; Guo W; Qiu S; Chen H
    Radiology; 2022 Aug; 304(2):397-405. PubMed ID: 35536131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Superiority of [
    Fu L; Huang S; Wu H; Dong Y; Xie F; Wu R; Zhou K; Tang G; Zhou W
    Eur Radiol; 2022 Sep; 32(9):6281-6290. PubMed ID: 35380229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Head-to-head comparison of
    Zhang J; Jiang S; Li M; Xue H; Zhong X; Li S; Peng H; Liang J; Liu Z; Rao S; Chen H; Cao Z; Gong Y; Chen G; Zhang R; Zhang L
    Cancer Imaging; 2023 Oct; 23(1):106. PubMed ID: 37899452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [
    Yang L; Xu S; Cheng L; Gao C; Cao S; Chang Z; Wang K
    Eur J Nucl Med Mol Imaging; 2023 Nov; 50(13):4051-4063. PubMed ID: 37542659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of [
    Chen H; Pang Y; Li J; Kang F; Xu W; Meng T; Shang Q; Zhao J; Guan Y; Wu H; Xie F; Wang J; Sun L
    Eur Radiol; 2023 Feb; 33(2):1329-1341. PubMed ID: 35976396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imaging fibroblast activation protein in liver cancer: a single-center post hoc retrospective analysis to compare [
    Guo W; Pang Y; Yao L; Zhao L; Fan C; Ke J; Guo P; Hao B; Fu H; Xie C; Lin Q; Wu H; Sun L; Chen H
    Eur J Nucl Med Mol Imaging; 2021 May; 48(5):1604-1617. PubMed ID: 33179149
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Li X; Lu N; Lin L; Chen Y; Yang S; Wang H; Liu X; Wu C; Xue X; Su X; Bai X; Liang T
    J Nucl Med; 2024 Feb; 65(2):206-212. PubMed ID: 38176719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of 18 F-FDG PET/CT and 68 Ga-FAPI-04 PET/CT in patients with non-small cell lung cancer.
    Can C; Kepenek F; Kömek H; Gündoğan C; Kaplan İ; Taşdemir B; Güzel Y; Agüloğlu N; Karaoğlan H
    Nucl Med Commun; 2022 Oct; 43(10):1084-1091. PubMed ID: 35972340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective Comparison of
    Lan L; Zhang S; Xu T; Liu H; Wang W; Feng Y; Wang L; Chen Y; Qiu L
    Radiology; 2022 Sep; 304(3):648-657. PubMed ID: 35579524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Head to head comparison of
    Zhang A; Meng X; Yao Y; Zhou X; Zhang Y; Li N
    Eur Radiol; 2024 Mar; 34(3):1960-1970. PubMed ID: 37668694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.